Rose-Mary Boustany

Title: The Innovative Contributions of Rose-Mary Boustany

Introduction

Rose-Mary Boustany is a distinguished inventor based in Beirut, Lebanon. She has made significant contributions to the field of neuroprotective therapies and genetic disorders. With a total of 2 patents, her work focuses on developing innovative solutions for complex medical challenges.

Latest Patents

One of her latest patents is titled "Functionalized pyridine carbamates with enhanced neuroprotective activity." This invention includes compositions and methods for treating subjects afflicted with neurodegenerative disorders. It involves administering an effective amount of a compound comprising a flupirtine derivative to the subject in need of treatment. Another notable patent is "Methods and compositions for treating disorders caused by a deficiency in a gene product of a CLN gene." This invention provides methods for treating disorders associated with deficiencies in CLN gene products, such as neuronal ceroid lipofuscinosis (NCL). It involves administering an effective amount of sphingolipids to the subject to treat the disorder.

Career Highlights

Rose-Mary Boustany has worked with prestigious institutions, including Duke University and the American University of Beirut. Her research has significantly advanced the understanding and treatment of neurodegenerative diseases and genetic disorders.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Paul Trippier and Nihar Kinarivala. These collaborations have further enriched her research and contributions to the field.

Conclusion

Rose-Mary Boustany's innovative work in neuroprotective therapies and genetic disorders highlights her commitment to advancing medical science. Her patents reflect her dedication to improving the lives of those affected by challenging health conditions.